Member Info for Theanalyzer

Dan55

If you looked at the AGM notice, a key part of the agenda is to allow shareholders to ask questions on accounts and then approve accounts, so your theory is nonsense.

Tintra’s AGM this am will be a joke and will have to be rescheduled to hold another to approve the audited accounts when they eventually emerge.

Tintra indicated that unaudited accounts would be published before AGM on 31 July 2023 in suspension RNS.

Failure to publish those would be down to the company.

Bunsen

It’s true that lots of smaller companies are struggling to get audited accounts out on time.

Tintra said it had been talking to technical specialists for 3 months so the issues don’t sound that straightforward.

For me the biggest concern is delay in getting the funding at 1178 pence.

Tintra needs a lot of cash based on its own reporting to build its business and if that is not forthcoming then there is an issue about its business model.

I actually like the idea of using AI in KYC and AML in emerging market banking just not convinced that Tintra has cash to deliver.

The odd circumstances around disposal of Tintra Acquisitions, the former intermediate holding company of Richard Shearer, raises some concerns as well.

Sharebel

The RNS indicates that Tintra engaged with technical specialists on the audit over 3 months ago.

It’s clearly something complex the auditors are grappling with if it takes over 3 months to audit. FTSE 100 companies got their accounts signed off by end of March i.e 3 months in total.

One issue facing all the Audit firms is that their regulator is pushing hard on level of audit documentation that is required before listed company sign offs.

Jeffrey’s Henry quit Public Interest Entity audit market I.e Main Market (mostly small market companies in their case)this has also reduced audit capacity for some companies.

What a shambolic state of affairs.

Six months to get audited accounts out for a group with 12 employees including Directors at end of last year.

Auditors qualified prior year accounts due to lack of appropriate evidence for two subsidiaries.

Occam

Your wrong.

Interims to 31 July 2022 were issued in RNS Oct 2022.

Finals to 31 Jan 2023 due by end of July 2023 per AIM deadline

TwoGoodToDie

I am not exactly a fan of SYME but you are wrong about the business model.

SYMEs client sell their inventory to a Stock Company, which SYME don’t own or control. The lenders to the stock company lend cash to the stock company which then provides the cash to SYME client.

SYME charge the stock company their fees.

There is no SYME inter company because SYME neither buys the inventory nor provides any cash.

AZ calls this a platform because it facilitates the transactions for a fee but doesnt enter into the underlying transactions.

The majority of assets are intangibles which were historically supported by reference to market cap of company as net present value of cash flows did support the value. Come this year end they will be heavily written down. Goodbye supposed asset support for share price

The CFO was paid £298,000 for 18 months to 30 September so it’s hardly a big commitment.

If company lasts only 2 months longer he is still ahead with his purchase even after tax.

Make more money

I was just answering another posters question.

Final results to 31 Jan 2023 due by end of July 2023.

Peak

Any reason why you are quoting the German regulator?

The U.K. regulator is of course the FCA and whilst rules are similar Brexit did change some of the aspects.

In any case U.K. Directors and PMDRs are also subject to insider trading rules which extend beyond the 30 close period around interim and year end financial statements. So if SYME had a significant deal in process, the Directors and PMDR couldn’t trade unless it was disclosed.

This is why SYME announced the U.K. IM was near completion before the Tradeflow deal because under the Tradeflow deal AZ used a controlled company TAG to buy more shares and thus he needed to ensure the market was aware of the proposed IM to avoid potential criticism of insider trading.

Bonga

They weren’t brought by an Employee Share Scheme because RNS would state the fact and SYME doesn’t have such a scheme.

They are small buys for people who I suspect earn multiples of the majority of punters praising the token buys.

This message will of course be deleted shortly.

They remain a loss making company albeit scale of loss and cash burn has been reduced. Crucially VRS don’t disclose how much cash they have left nor disposal timescale for mature businesses or Hanwha assets.

I suspect they will get approval for increase in share capital so they can do another placing but who will want to fund a placing in VRS at current low market cap?

I find it odd that the headline cash consideration of £14 million is offset by future deferred consideration of £12 million but the audited accounts for 2022 showed that no further deferred consideration was payable to Tradeflow vendors and reduced the amount credited for the year ended 31 December 2021.

If Tradeflow performance since then had been so strong surely there would have been an RNS?

Ginger

Tradeflow was never valued at £31 million in audited accounts.

2021 accounts show an initial price of £7 million plus deferred consideration accounted for as remuneration of £4 million so a total of £11 million.

The deferred consideration was reduced to just £700,000 in December 2022 accounts.

SYME has also written down Tradeflow in both 2021 and 2022 accounts because it was less valuable.

A complex deal but it looks like a loss to me.

SYME get £2 million over time from TAG for 81% of Tradeflow sold.

SYME paid £4 million in cash for 100% of TAG plus shares worth £3 million and issued shares worth £2 million to people who facilitated the deal and valued the Tradeflow.

Yes there is a call option over remaining 19% of Tradeflow which might generate more cash but on known facts at present SYME has made a large loss on the purchase of Tradeflow.

Savvy

TW will be arrested for what? Writing negative articles based on company issued RNS announcements.

Your conspiracy theories get ever more amusing and desperate.

SYME share price simply reflects its poor historical track record and the poor revenue visibility for the future where the company itself provides no guidance to the market.

Do not panic

Yes VRS could be ramped and spike again because of its low market cap but as a long term investment it is a dog.

Graphene sales made at a gross loss even before other costs and without DSTL contract were tiny.

Legacy businesses revenues were down and losses were up so don’t expect a massive net proceeds.

Have you been spiked trying to trade this?

Rhodi the ramper returns to bleat about Tern’s poor performance.

Turns out that I was right about it being overvalued with a low quality portfolio and running a high expense ratio.

Tern looks set to sell of more Wyld shares and hold a dilutive placing to carry on funding its high operating cost base and fund loss making portfolio.

At current share price any share issue will dilute existing net assets even further.